Rachel Sacks‐Davis

3.4k total citations
79 papers, 1.8k citations indexed

About

Rachel Sacks‐Davis is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Rachel Sacks‐Davis has authored 79 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Epidemiology, 52 papers in Hepatology and 21 papers in Infectious Diseases. Recurrent topics in Rachel Sacks‐Davis's work include Hepatitis C virus research (51 papers), Liver Disease Diagnosis and Treatment (29 papers) and HIV, Drug Use, Sexual Risk (28 papers). Rachel Sacks‐Davis is often cited by papers focused on Hepatitis C virus research (51 papers), Liver Disease Diagnosis and Treatment (29 papers) and HIV, Drug Use, Sexual Risk (28 papers). Rachel Sacks‐Davis collaborates with scholars based in Australia, Netherlands and United States. Rachel Sacks‐Davis's co-authors include Margaret Hellard, Judy Gold, Alisa Pedrana, Mark Stoové, Campbell Aitken, Peter Higgs, David A. Rolls, Garry Robins, Philippa Pattison and Jason Grebely and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Hepatology.

In The Last Decade

Rachel Sacks‐Davis

74 papers receiving 1.7k citations

Peers

Countries citing papers authored by Rachel Sacks‐Davis

Since Specialization

Citations

This map shows the geographic impact of Rachel Sacks‐Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel Sacks‐Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel Sacks‐Davis more than expected).

Fields of papers citing papers by Rachel Sacks‐Davis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel Sacks‐Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel Sacks‐Davis. The network helps show where Rachel Sacks‐Davis may publish in the future.

Co-authorship network of co-authors of Rachel Sacks‐Davis

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel Sacks‐Davis. A scholar is included among the top collaborators of Rachel Sacks‐Davis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel Sacks‐Davis. Rachel Sacks‐Davis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Improving Hepatocellular Carcinoma Surveillance Outcomes in Patients with Cirrhosis after Hepatitis C Cure: A Modelling Study 2024 ·Cancers ·(unknown), Nick Scott, Jessica Howell, (unknown), (unknown), Margaret Hellard, (unknown), Marno Ryan, Tom Sutherland, Alexander Thompson, Joseph Doyle, Rachel Sacks‐Davis	1
2	A Framework for Assessing the Impact of Outbreak Response Immunization Programs 2024 ·SHILAP Revista de lepidopterología ·Dominic Delport, Benjamin M. Sanderson, Rachel Sacks‐Davis, Stefanie Vaccher, (unknown), Rowan Martin‐Hughes, Tewodaj Mengistu, Dan Hogan, Romesh Abeysuriya, Nick Scott	2
3	Hepatitis C virus reinfection incidence among gay and bisexual men with HIV in Australia from 2016 to 2020 2024 ·Liver International ·(unknown), Rachel Sacks‐Davis, Daniela K van Santen, Michael W. Traeger, Anna L. Wilkinson, Jason Asselin, Christopher K. Fairley, Norman Roth, Mark Bloch, Gail Matthews, Basil Donovan, Rebecca Guy, Mark Stoové, Margaret Hellard, Joseph Doyle	2
4	Phenotyping people with a history of injecting drug use within electronic medical records using an interactive machine learning approach 2024 ·npj Digital Medicine ·Carol El‐Hayek, (unknown), Margaret Hellard, M. David Curtis, Rachel Sacks‐Davis, (unknown), Jason Asselin, Douglas Boyle, Anna L. Wilkinson, (unknown), Jane S. Hocking, Adam G. Dunn	1
5	Annual hepatitis C testing and positive tests among gay and bisexual men in Australia from 2016 to 2022: a serial cross-sectional analysis of sentinel surveillance data 2024 ·Sexually Transmitted Infections ·(unknown), Rachel Sacks‐Davis, Michael W. Traeger, Daniela K van Santen, Anna L. Wilkinson, Jason Asselin, Christopher K. Fairley, (unknown), Mark Bloch, Gail Matthews, Basil Donovan, Rebecca Guy, Margaret Hellard, Joseph Doyle	1
6	Characteristics of attrition within the SuperMIX cohort of people who inject drugs: a multiple event discrete-time survival analysis 2024 ·BMC Medical Research Methodology ·(unknown), Paul A. Agius, Rachel Sacks‐Davis, Amanda Roxburgh, Michael Livingston, Lisa Maher, Matthew Hickman, Paul Dietze	0
7	Risk of Primary Incident Hepatitis C Infection Following Bacterial Sexually Transmissible Infections Among Gay and Bisexual Men in Australia From 2016 to 2020 2024 ·Open Forum Infectious Diseases ·(unknown), Rachel Sacks‐Davis, Paul A. Agius, Daniela K van Santen, Michael W. Traeger, Anna L. Wilkinson, Jason Asselin, Christopher K. Fairley, Norman Roth, Mark Bloch, Gail Matthews, Basil Donovan, Rebecca Guy, Mark Stoové, Margaret Hellard, Joseph Doyle	1
8	COVID-19 outbreaks in residential aged care facilities: an agent-based modeling study 2024 ·Frontiers in Public Health ·(unknown), Rachel Sacks‐Davis, Romesh Abeysuriya, Dominic Delport, (unknown), (unknown), Suman Majumdar, Margaret Hellard, Nick Scott	1
9	Keeping kids in school: modelling school-based testing and quarantine strategies during the COVID-19 pandemic in Australia 2023 ·Frontiers in Public Health ·Romesh Abeysuriya, Rachel Sacks‐Davis, Katherine Heath, Dominic Delport, Fiona M. Russell, Margie Danchin, Margaret Hellard, Jodie McVernon, Nick Scott	6
10	Incidence and Prevalence of Hepatitis C Virus Among HIV-Negative Gay and Bisexual Men Using HIV Pre-exposure Prophylaxis (PrEP): A Systematic Review and Meta-analysis 2023 ·Open Forum Infectious Diseases ·(unknown), (unknown), Rachel Sacks‐Davis, Daniela K van Santen, Vincent J. Cornelisse, Edwina Wright, Margaret Hellard, Joseph Doyle, Mark Stoové	9
11	Impact of COVID‐19 lockdown restrictions on hepatitis C testing in Australian primary care services providing care for people who inject drugs 2022 ·Journal of Viral Hepatitis ·Michael W. Traeger, Daniela K van Santen, Rachel Sacks‐Davis, Jason Asselin, Allison Carter, Joseph Doyle, Alisa Pedrana, Anna L. Wilkinson, Jessica Howell, (unknown), (unknown), Basil Donovan, Rebecca Guy, Margaret Hellard, Mark Stoové	6
12	Hepatitis C incidence among patients attending primary care health services that specialise in the care of people who inject drugs, Victoria, Australia, 2009 to 2020 2022 ·International Journal of Drug Policy ·Anna L. Wilkinson, Daniela K van Santen, Michael W. Traeger, Rachel Sacks‐Davis, Jason Asselin, Nick Scott, (unknown), Joseph Doyle, Carol El‐Hayek, Jessica Howell, (unknown), Hamish McManus, Basil Donovan, Mark Stoové, Margaret Hellard, Alisa Pedrana	6
13	Modelling the impact of reducing control measures on the COVID-19 pandemic in a low transmission setting 2020 ·The Medical Journal of Australia ·Nick Scott, Anna Palmer, Dominic Delport, Romesh Abeysuriya, Robyn M. Stuart, Cliff C. Kerr, (unknown), Daniel J. Klein, Rachel Sacks‐Davis, Katherine Heath, (unknown), Alisa Pedrana, Mark Stoové, David Wilson, Margaret Hellard	2
14	Modeling of patient virus titers suggests that availability of a vaccine could reduce hepatitis C virus transmission among injecting drug users 2018 ·Science Translational Medicine ·Marian Major, Alexander Gutfraind, Louis Shekhtman, (unknown), A. V. Kachko, Scott J. Cotler, Behzad Hajarizadeh, Rachel Sacks‐Davis, Kimberly Page, Basmattee Boodram, Harel Dahari	35
15	Venue-Based Networks May Underpin HCV Transmissions amongst HIV-Infected Gay and Bisexual Men 2016 ·PLoS ONE ·Daniel Bradshaw, Jayna Raghwani, Brendan Jacka, Rachel Sacks‐Davis, F. Lamoury, Ian Down, Garrett Prestage, Tanya Applegate, Margaret Hellard, Joe Sasadeusz, Gregory J. Dore, Oliver G. Pybus, Gail Matthews, Mark Danta	9
16	Response to treatment following recently acquired hepatitis C virus infection in a multicentre collaborative cohort 2015 ·Journal of Viral Hepatitis ·Joseph Doyle, Katja Deterding, Jason Grebely, H. Wedemeyer, Rachel Sacks‐Davis, Tim Spelman, Gail Matthews, Thomas Rice, Meghan D. Morris, Barbara McGovern, Arthur Y Kim, Julie Bruneau, Andrew R. Lloyd, Kimberly Page, Michael P. Manns, Margaret Hellard, Gregory J. Dore	8
17	Hepatitis C transmission and treatment as prevention – The role of the injecting network 2015 ·International Journal of Drug Policy ·Margaret Hellard, Emma S. McBryde, Rachel Sacks‐Davis, David A. Rolls, Peter Higgs, Campbell Aitken, A. Thompson, Joseph Doyle, Philippa Pattison, Garry Robins	54
18	Interferon lambda 3 genotype predicts hepatitis C virus RNA levels in early acute infection among people who inject drugs: The InC3 Study 2014 ·Journal of Clinical Virology ·Behzad Hajarizadeh, Bart Grady, Kimberly Page, Arthur Y. Kim, Barbara McGovern, Andrea L. Cox, Thomas Rice, Rachel Sacks‐Davis, Julie Bruneau, Meghan D. Morris, Janaki Amin, Janke Schinkel, Tanya Applegate, Lisa Maher, Margaret Hellard, Andrew R. Lloyd, Maria Prins, Ronald B. Geskus, Gregory J. Dore, Jason Grebely	7
19	1178 MOLECULAR EPIDEMIOLOGY OF HEPATITIS C IN A SOCIAL NETWORK OF YOUNG PEOPLE WHO INJECT DRUGS 2011 ·Journal of Hepatology ·Rachel Sacks‐Davis, Galina Daraganova, Campbell Aitken, Peter Higgs, (unknown), D. Scott Bowden, Garry Robins, Philippa Pattison, Jason Grebely, Alyssa E. Barry, Margaret Hellard	1
20	Home-based chlamydia testing of young people attending a music festival - who will pee and post? 2010 ·BMC Public Health ·Rachel Sacks‐Davis, Judy Gold, Campbell Aitken, Margaret Hellard	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact